Company research
DICE Therapeutics, Inc.
CIK 1645569Updated Nov 16, 2026
Securities
Historical securities (1)
DICE · NASDAQ · equity · closed Aug 9, 2023Name history
DiCE Molecules Holdings, LLC · through Sep 10, 2021DiCE MOLECULES HOLDINGS, LLC · through Sep 10, 2021
DICE price & chart
Historical security
This listing closed Aug 9, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| ASSETS | |||
| AssetsUSD | 593,978,000Source | 325,754,000Source | 63,861,000Source |
| Property, Plant and Equipment, NetUSD | 2,921,000Source | 1,645,000Source | 1,656,000Source |
| Current assets: | |||
| Cash and Cash Equivalents, at Carrying ValueUSD | 461,393,000Source | 115,826,000Source | 59,687,000Source |
| Assets, CurrentUSD | 577,762,000Source | 323,911,000Source | 62,051,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 3,537,000Source | 2,440,000Source | 364,000Source |
| Operating Lease, Right-of-Use AssetUSD | 13,097,000Source | — | — |
| Other Assets, NoncurrentUSD | — | — | 5,000Source |
| LIABILITIES AND EQUITY | |||
| LiabilitiesUSD | 26,990,000Source | 12,805,000Source | 9,632,000Source |
| Stockholders’ equity: | |||
| Common Stock, Value, IssuedUSD | 5,000Source | — | — |
| Additional Paid in CapitalUSD | 755,174,000Source | 416,710,000Source | 1,603,000Source |
| Retained Earnings (Accumulated Deficit)USD | -187,594,000Source | -103,707,000Source | -54,748,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -597,000Source | -58,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 566,988,000Source | 312,949,000Source | -53,145,000Source |
| Liabilities and EquityUSD | 593,978,000Source | 325,754,000Source | 63,861,000Source |
| Current liabilities: | |||
| Liabilities, CurrentUSD | 15,149,000Source | 10,881,000Source | 9,290,000Source |
| Operating Lease, Liability, CurrentUSD | 1,424,000Source | — | — |
| Accounts Payable, CurrentUSD | 3,075,000Source | 1,710,000Source | 5,086,000Source |
| Operating Lease, Liability, NoncurrentUSD | 11,841,000Source | — | — |
| Additional Financial Items | |||
| Deferred Revenue, CurrentUSD | — | — | 1,125,000Source |
| Long-term Debt, Excluding Current Maturities | — | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | — | 1,916,000Source | — |
cash flow · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Cash flows from operating activities: | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 12,825,000Source | 5,581,000Source | 556,000Source |
| Changes in operating assets and liabilities: | |||
| Increase (Decrease) in Accounts ReceivableUSD | -1,500,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | 1,334,000Source | -772,000Source | 1,411,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -64,322,000Source | -39,292,000Source | -20,679,000Source |
| Cash flows from investing activities: | |||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 87,487,000Source | -204,624,000Source | 18,003,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,237,000Source | 718,000Source | 148,000Source |
| Cash flows from financing activities: | |||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 322,252,000Source | 300,254,000Source | 53,895,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 461,591,000Source | 116,174,000Source | 59,836,000Source |
| Supplemental disclosure of cash flow information: | |||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 76,000Source | 81,000Source | — |
| Additional Financial Items | |||
| Share-based Payment Arrangement, ExpenseUSD | 12,825Source | 5,581,000Source | 556,000Source |
| Amortization of Debt Issuance CostsUSD | — | 107,000Source | — |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | 0Source | — | — |
| DepreciationUSD | 825,000Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | 28,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | -200,000Source | — | — |
| General and Administrative ExpenseUSD | 25,662,000Source | 12,222,000Source | 5,004,000Source |
| Marketable Securities, Unrealized Gain (Loss)USD | -539,000Source | -58,000Source | -8,000Source |
| Net Income (Loss) Attributable to ParentUSD | -83,887,000Source | -48,959,000Source | -23,739,000Source |
| Operating ExpensesUSD | 88,221,000Source | 48,728,000Source | 24,584,000Source |
| Operating Lease, ExpenseUSD | 1,400,000Source | 1,400,000Source | 1,500,000Source |
| Proceeds from Issuance of Common StockUSD | 1,412,000Source | — | — |
| Proceeds from Issuance of Long-term DebtUSD | — | 2,416,000Source | — |
income statement · annual statements
| Line item | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Total RevenueUSD | — | 1,125,000Source | 863,000Source |
| Operating Income (Loss)USD | -88,221,000Source | -47,603,000Source | -23,721,000Source |
| Net Income (Loss) Attributable to ParentUSD | -83,887,000Source | -48,959,000Source | -23,739,000Source |
| Earnings Per Share, BasicUSD per share | -2.13Source | — | — |
| Earnings Per Share, DilutedUSD per share | -2.13Source | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 39,401,106Source | — | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 39,401,106Source | — | — |
| Additional Financial Items | |||
| Depreciation, Depletion and Amortization, NonproductionUSD | — | 661,000Source | 697,000Source |
| General and Administrative ExpenseUSD | 25,662,000Source | 12,222,000Source | 5,004,000Source |
| Interest ExpenseUSD | — | 174,000Source | 13,000Source |
| Operating ExpensesUSD | 88,221,000Source | 48,728,000Source | 24,584,000Source |
| Operating Lease, ExpenseUSD | 1,400,000Source | 1,400,000Source | 1,500,000Source |
| Research and Development ExpenseUSD | 62,559,000Source | 36,506,000Source | 19,580,000Source |